Putnam Investments LLC Amneal Pharmaceuticals, Inc. Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 69,593 shares of AMRX stock, worth $640,255. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,593
Previous 152,621
54.4%
Holding current value
$640,255
Previous $644,000
34.47%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AMRX
# of Institutions
186Shares Held
140MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$201 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$129 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$113 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$104 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$98.6 Million2.02% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.39B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...